# Tolerance to Target Doses of Thiazides in Actual Practice: A Feasibility Study

> **NCT01235377** · PHASE4 · COMPLETED · sponsor: **VA Pharmacy Benefits Management Strategic Healthcare Group** · enrollment: 20 (actual)

## Conditions studied

- Hypertension

## Interventions

- **OTHER:** Favor one of two thiazides for new prescriptions & attempt target dose

## Key facts

- **NCT ID:** NCT01235377
- **Lead sponsor:** VA Pharmacy Benefits Management Strategic Healthcare Group
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-10
- **Final completion:** 2014-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01235377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01235377, "Tolerance to Target Doses of Thiazides in Actual Practice: A Feasibility Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01235377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*